ASTRAZENECA UK LIMITED

Active Cambridge

Activities of head offices

10,459 employees website.com
Life sciences and medical technology Activities of head offices
A

ASTRAZENECA UK LIMITED

Activities of head offices

Founded 26 Nov 1998 Active Cambridge, United Kingdom 10,459 employees website.com
Life sciences and medical technology Activities of head offices

Previous Company Names

ASTRAZENECA PHARMA LIMITED 5 Apr 1999 — 3 Aug 1999
ASTRAZENECA LIMITED 16 Dec 1998 — 5 Apr 1999
LETTERPLANT LIMITED 26 Nov 1998 — 16 Dec 1998
Accounts Submitted 7 Aug 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 17 Nov 2025 Next due 1 Dec 2026 7 months remaining
Net assets £42,578M £27,346M 2024 year on year
Total assets £49,258M £28,041M 2024 year on year
Total Liabilities £6,680M £695M 2024 year on year
Charges 5
4 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ASTRAZENECA UK LIMITED (03674842), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 26 Nov 1998. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£9.00M

Decreased by £4.00M (-31%)

Net Assets

£42578.00M

Increased by £27346.00M (+180%)

Total Liabilities

£6680.00M

Increased by £695.00M (+12%)

Turnover

£15120.00M

Increased by £717.00M (+5%)

Employees

10459

Increased by 402 (+4%)

Debt Ratio

14%

Decreased by 14 (-50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 5

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Elaine HarropDirectorBritishEngland5127 Jun 2024Active

Shareholders

Shareholders (2)

Astrazeneca Intermediate Holdings Limited
100.0%
8,430,992,443
Astrazeneca Plc
0.0%
510,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ASTRAZENECA UK LIMITED Current Company

Charges

Charges

4 outstanding 1 satisfied

Properties

Properties

7 freehold 34 leasehold 41 total
AddressTenurePrice PaidDate Added
Land on the south-west side of Astrazeneca, Charter Way, Silk Road Business Park, Macclesfield (SK10 2NA) CHESHIRE EAST
Freehold-26 Jun 2025
Ninth Floor, 2 Pancras Square, London (N1C 4AG) CAMDEN
Leasehold-5 Feb 2024
Seventh Floor, 2 Pancras Square, London (N1C 4AG) CAMDEN
Leasehold-5 Feb 2024
Eighth Floor, 2 Pancras Square, London (N1C 4AG) CAMDEN
Leasehold-5 Feb 2024
Rooms on the Ground Floor and Second Floor, Anne McLaren Building, Francis Crick Avenue, Cambridge (CB2 0BA) CAMBRIDGE
Leasehold-21 Feb 2023
Land on the south-west side of Astrazeneca, Charter Way, Silk Road Business Park, Macclesfield (SK10 2NA)
Freehold
Added 26 Jun 2025
District CHESHIRE EAST
Ninth Floor, 2 Pancras Square, London (N1C 4AG)
Leasehold
Added 5 Feb 2024
District CAMDEN
Seventh Floor, 2 Pancras Square, London (N1C 4AG)
Leasehold
Added 5 Feb 2024
District CAMDEN
Eighth Floor, 2 Pancras Square, London (N1C 4AG)
Leasehold
Added 5 Feb 2024
District CAMDEN
Rooms on the Ground Floor and Second Floor, Anne McLaren Building, Francis Crick Avenue, Cambridge (CB2 0BA)
Leasehold
Added 21 Feb 2023
District CAMBRIDGE

Documents

Company Filings

DateCategoryDescriptionDocument
9 Feb 2026OfficersTermination of Pablo Panella as director on 1 Feb 2026
11 Dec 2025OfficersChange to director Lutz Jermutus on 10 Dec 2025
17 Nov 2025Confirmation StatementConfirmation statement made on 17 Nov 2025 with no updates
7 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
2 May 2025OfficersAppointment of Matthew Shaun Bowden as director on 1 May 2025
9 Feb 2026 Officers

Termination of Pablo Panella as director on 1 Feb 2026

11 Dec 2025 Officers

Change to director Lutz Jermutus on 10 Dec 2025

17 Nov 2025 Confirmation Statement

Confirmation statement made on 17 Nov 2025 with no updates

7 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

2 May 2025 Officers

Appointment of Matthew Shaun Bowden as director on 1 May 2025

Recent Activity

Latest Activity

Termination of Pablo Panella as director on 1 Feb 2026

2 months ago on 9 Feb 2026

Change to director Lutz Jermutus on 10 Dec 2025

4 months ago on 11 Dec 2025

Confirmation statement made on 17 Nov 2025 with no updates

5 months ago on 17 Nov 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 7 Aug 2025

Appointment of Matthew Shaun Bowden as director on 1 May 2025

12 months ago on 2 May 2025